{
    "clinical_study": {
        "@rank": "114249", 
        "acronym": "AIRPEDIA", 
        "arm_group": [
            {
                "arm_group_label": "Telemedicine", 
                "arm_group_type": "Experimental", 
                "description": "care and follow-up through telemedicine."
            }, 
            {
                "arm_group_label": "Conventional care", 
                "arm_group_type": "Active Comparator", 
                "description": "care and follow-up through iterative diabetes physician consultations (conventional care and follow-up)"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is to assess the cost-effectiveness of telemedicine in the care of\n      chronic diabetic foot ulcers.\n\n      Patients will be randomized into 2 groups: 1/conventional care group with iterative visits\n      to diabetes specialist or 2/innovative care (telemedicine group).\n\n      the health insurance system perspective is adopted."
        }, 
        "brief_title": "Medico-economical Assessment of Telemedicine During Chronic Diabetes-related Foot Wound Management", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Diabetic Foot Ulcer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Ulcer", 
                "Foot Ulcer", 
                "Diabetic Foot"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with type 1 or 2 diabetes, at least 18 years old\n\n          -  Patient with a diabetic foot wound :\n\n               -  Acute or chronic (evolving for at least 30 days)\n\n               -  size \u2264 to 3 cm\u00b2\n\n               -  Level I, II or III, stage A or B, excluding stages C and D from the University\n                  of Texas Wound Classification Systems\n\n          -  Person affiliated to French Health insurance or equivalent\n\n          -  Person having signed freely the consent form after receiving sufficient information\n\n          -  Treatment compliance and 6 months follow-up feasible\n\n        Exclusion Criteria:\n\n          -  Patient with a ischemic wound: Ankle-Brachial Index (ABI) <0.9 or Transcutaneous\n             oxygen pressure (TcpO2) < 30 mmHg (stage C and D from the University of Texas Wound\n             Classification Systems)\n\n          -  Patient with emergency hospitalization indication whatever the reasons.\n\n          -  Person deprived of liberty by a legal or administrative decision, patients in\n             emergency and people hospitalised without consent and who are not protected by law.\n\n          -  Pregnant or breastfeeding women\n\n          -  Patient currently participating in another telemedicine research protocol (such as :\n             Study on the impact of Telemedicine on the management of patients with type 1\n             diabetes (TELEDIAB-3))"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "64", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01814267", 
            "org_study_id": "DCIC 12 07"
        }, 
        "intervention": [
            {
                "arm_group_label": "Telemedicine", 
                "description": "Intervention group: care and follow-up through telemedicine (e-consultations)\n1 hospital consultation at inclusion time, week 0\nthen every 15 days, after the transmission of medical data and photos via internet by the nurse, telemedicine e-consultations until the wound has healed (week 2,week 4, week 6, week 8, week 10, week 12, week 14, week 16, week 18, week 20, week 22, week 24 : end point study), i.e. 12 e-consultations over a 6-month period.\n1 hospital consultation to validate that the wound is well-healed", 
                "intervention_name": "telemedicine", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Conventional care", 
                "description": "conventional group: iterative diabetes physicians consultations at hospital\n1 consultation at inclusion time, week 0\n1 consultation 2 weeks after inclusion, week 2\n1 consultation per month until the wound has healed (week 4, week 8, week 12, week 16, week 20, week 24: end-point study), i.e. 6 consultations over a 6-month period\n1 consultation to validate that the wound is well-healed", 
                "intervention_name": "conventional", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "innovative care", 
            "telemedicine", 
            "cost effectiveness", 
            "diabetes"
        ], 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "contact": {
                "email": "PYBenhamou@chu-grenoble.fr", 
                "last_name": "Pierre-Yves BENHAMOU, PU PH", 
                "phone": "0033476769349"
            }, 
            "contact_backup": {
                "email": "MMuller@chu-grenoble.fr", 
                "last_name": "Marie MULLER, MD", 
                "phone": "0033476765165"
            }, 
            "facility": {
                "address": {
                    "city": "Grenoble", 
                    "country": "France", 
                    "zip": "38049"
                }, 
                "name": "University Hospital of Grenoble"
            }, 
            "investigator": {
                "last_name": "Marie MULLER, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "SDavidTchouda@chu-grenoble.fr", 
            "last_name": "Sandra DAVID TCHOUDA, MD PHD", 
            "phone": "0033476767186"
        }, 
        "overall_contact_backup": {
            "email": "MProust@chu-grenoble.fr", 
            "last_name": "Marion PROUST, CRA", 
            "phone": "0033476767312"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Grenoble", 
            "last_name": "Pierre-Yves BENHAMOU, MD PHD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "It is elaborated from:\nMain cost criteria: transport, outpatient costs (home nursing care, physicians consultations...), loss of productivity (absence from work)\nMain clinical effectiveness criterion: wound healing time.", 
            "measure": "Assess the incremental cost-effectiveness ratio from the french health  system perspective", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "reference": [
            {
                "PMID": "22067285", 
                "citation": "Hazenberg CE, Bus SA, Kottink AI, Bouwmans CA, Sch\u00f6nbach-Spraul AM, van Baal SG. Telemedical home-monitoring of diabetic foot disease using photographic foot imaging--a feasibility study. J Telemed Telecare. 2012 Jan;18(1):32-6. doi: 10.1258/jtt.2011.110504. Epub 2011 Nov 8."
            }, 
            {
                "PMID": "21568750", 
                "citation": "Foltynski P, Ladyzynski P, Migalska-Musial K, Sabalinska S, Ciechanowska A, Wojcicki J. A new imaging and data transmitting device for telemonitoring of diabetic foot syndrome patients. Diabetes Technol Ther. 2011 Aug;13(8):861-7. doi: 10.1089/dia.2011.0004. Epub 2011 May 13."
            }, 
            {
                "PMID": "21134035", 
                "citation": "Bowling FL, King L, Paterson JA, Hu J, Lipsky BA, Matthews DR, Boulton AJ. Remote assessment of diabetic foot ulcers using a novel wound imaging system. Wound Repair Regen. 2011 Jan-Feb;19(1):25-30. doi: 10.1111/j.1524-475X.2010.00645.x. Epub 2010 Dec 6."
            }, 
            {
                "PMID": "17059653", 
                "citation": "Larsen SB, Clemensen J, Ejskjaer N. A feasibility study of UMTS mobile phones for supporting nurses doing home visits to patients with diabetic foot ulcers. J Telemed Telecare. 2006;12(7):358-62."
            }, 
            {
                "PMID": "15192491", 
                "citation": "Wilbright WA, Birke JA, Patout CA, Varnado M, Horswell R. The use of telemedicine in the management of diabetes-related foot ulceration: a pilot study. Adv Skin Wound Care. 2004 Jun;17(5 Pt 1):232-8."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01814267"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Grenoble", 
            "investigator_full_name": "AdministrateurCIC", 
            "investigator_title": "Pr Pierre-Yves BENHAMOU, University Hospital, Grenoble", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The incremental cost-effectiveness ratio is calculated from the hospital perspective:\nMain cost criteria will be collected according to the micro-costing method: costs of innovative medical device (implementation and maintenance of telemedicine platform), telemedicine physician consultations, standard consumables, cost of care rooms and cost of medical and paramedical staff and, standard consumables for wound treatment.\nCosts will not include structural costs\nMain clinical effectiveness criterion: wound healing time", 
                "measure": "Assess the Impact of telemedicine care from the hospital perspective", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Acceptability questionnaire for nurse including use or misuse of telemedicine. Acceptability questionnaire for patient.", 
                "measure": "Assess acceptability of telemedicine care (compliance and satisfaction) for patients and nurses.", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}